Evidence map›Paper›PMID 32210298›Full record

ArticleScientific reports2020

CYP2J2 Modulates Diverse Transcriptional Programs in Adult Human Cardiomyocytes.

Eric A Evangelista, Theresa Aliwarga, Nona Sotoodehnia, Paul N Jensen, Barbara McKnight, Rozenn N Lemaitre, Rheem A Totah, Sina A Gharib

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eric A EvangelistaDepartment of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, WA, USA.
Theresa AliwargaDepartment of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, WA, USA.
Nona SotoodehniaCardiovascular Health Research Unit, Department of Medicine, Seattle, WA, USA.
Paul N JensenCardiovascular Health Research Unit, Department of Medicine, Seattle, WA, USA.
Barbara McKnightCardiovascular Health Research Unit, Department of Medicine, Seattle, WA, USA.
Rozenn N LemaitreCardiovascular Health Research Unit, Department of Medicine, Seattle, WA, USA.
Rheem A TotahDepartment of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, WA, USA. rtotah@uw.edu.
Sina A GharibCardiovascular Health Research Unit, Department of Medicine, Seattle, WA, USA. sagharib@uw.edu.
University of Washington · US

Funding

Pharmacological Sciences SupplementT32GM007750 · NIGMS · UNIVERSITY OF WASHINGTON · PI ATKINS, WILLIAM M · 1985 to 2023
$12.6M
NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
CYP2J2 Mediated Eicosanoids in Arrhythmias and Sudden Cardiac ArrestR01HL128709 · NHLBI · UNIVERSITY OF WASHINGTON · PI SOTOODEHNIA, NONA, TOTAH, RHEEM ANGELA · 2015 to 2018
$2.9M
Institute of Translational Health SciencesTL1TR000422 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$2.1M
NCATS NIH HHS TL1 TR000422NCATS NIH HHS TL1 TR002318NHLBI NIH HHS R01 HL128709NIGMS NIH HHS T32 GM007750
6 · The paper itself

Abstract

CYP2J2, a member of the Cytochrome P450 family of enzymes, is the most abundant epoxygenase in the heart and has multifunctional properties including bioactivation of arachidonic acid to epoxyeicosatrienoic acids, which, in turn, have been implicated in mediating several cardiovascular conditions. Using a proteomic approach, we found that CYP2J2 expression is lower in cardiac tissue from patients with cardiomyopathy compared to controls. In order to better elucidate the complex role played by CYP2J2 in cardiac cells, we performed targeted silencing of CYP2J2 expression in human adult ventricular cardiomyocytes and interrogated whole genome transcriptional responses. We found that knockdown of CYP2J2 elicits widespread alterations in gene expression of ventricular cardiomyocytes and leads to the activation of a diverse repertoire of programs, including those involved in ion channel signaling, development, extracellular matrix, and metabolism. Several members of the differentially up-regulated ion channel module have well-known pathogenetic roles in cardiac dysrhythmias. By leveraging causal network and upstream regulator analysis, we identified several candidate drivers of the observed transcriptional response to CYP2J2 silencing; these master regulators have been implicated in aberrant cardiac remodeling, heart failure, and myocyte injury and repair. Collectively, our study demonstrates that CYP2J2 plays a central and multifaceted role in cardiomyocyte homeostasis and provides a framework for identifying critical regulators and pathways influenced by this gene in cardiovascular health and disease.

Indexed as

AdultCardiomyopathiesCytochrome P-450 CYP2J2Cytochrome P-450 Enzyme SystemFemaleGene ExpressionHumansMaleMyocardiumMyocytes, CardiacPrimary Cell CultureProteomicsSignal TransductionCYP2J2 protein, humanCytochrome P-450 CYP2J2Cytochrome P-450 Enzyme System

Identifiers

PMID32210298
PMCPMC7093536
OpenAlexW3013368751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.